EUVIMEDEUVIMED entdecken
Open Access

Mendelian randomization study on simvastatin and gastric cancer: exploring the therapeutic potential of statins in oncology

Jiazhong Wang, Gang Cao, Yang Liu, Suo Chen, Haoyu Li, Bo Zheng

Translational Cancer Research · 2024-09 · 13 (9) · 4671-4677

DOI: 10.21037/tcr-24-576 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Cancer Research, 2024-09. Verfasst von Jiazhong Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid Surgery, Second Affiliated Hospital, Xi'an Jiaotong University School of Medicine, Xi'an, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gastric cancer ranks as the fifth most prevalent cancer and the third leading cause of cancer-related mortality worldwide, Statins, renowned for their cholesterol-lowering effects, have garnered interest for their potential roles in cancer prevention and treatment due to their pleiotropic effects, such as anti-proliferative, pro-apoptotic, and anti-inflammatory properties. This study aims to investigate the therapeutic potential of simvastatin, a widely prescribed statin, in the context of gastric cancer using Mendelian randomization (MR) to explore a possible causal relationship between simvastatin use and gastric cancer risk.

Methods

We conducted a two-sample MR analysis utilizing summary statistics from genome-wide association studies (GWAS). Data from the Integrative Epidemiology Unit (IEU) Open GWAS project included 462,933 participants and 9,851,867 single nucleotide polymorphisms (SNPs) for simvastatin, and 476,116 participants with 24,188,662 SNPs for gastric cancer. Instrumental variables screening criteria were stringent, resulting in 41 valid SNPs as instrumental variables. The MR analysis was performed using the inverse variance weighting (IVW), supplemented by MR-Egger, weighted median estimator (WME), weighted mode, and simple mode approaches. Heterogeneity and pleiotropy were assessed using IVW, MR-Egger tests, and the MR-PRESSO method.

Results

The IVW and WME analyses indicated a significant protective effect of simvastatin against gastric cancer [IVW: odds ratio (OR) =0.1459, 95% confidence interval (CI): -3.502 to -0.346, P=0.01; WME: OR =0.0347, 95% CI: -3.521 to 0.1610, P=0.03]. There was no significant difference between the results of the two MR analyses before and after the removal of outliers (P=0.76), and the Egger-intercept for horizontal pleiotropy testing was not significant (P=0.38). Leave-one-out sensitivity analysis supported the robustness of our findings.

Conclusions

This MR study provides evidence for a potential protective effect of simvastatin against gastric cancer, suggesting its consideration as an adjunct to traditional cancer therapies.

Schlagwörter

Stichwörter der Autor:innen

Mendelian randomization (MR)gastric cancersimvastatinsingle nucleotide polymorphism (SNP)therapeutic potential

Autor:innen und Institutionen

  • Department of Thyroid Surgery, Second Affiliated Hospital, Xi'an Jiaotong University School of Medicine, Xi'an, China.
  • Department of General Surgery, Xi'an Gaoxin Hospital, Xi'an, China.

Zitieren

APA

Wang, J., Cao, G., Liu, Y., Chen, S., Li, H., & Zheng, B. (2024). Mendelian randomization study on simvastatin and gastric cancer: exploring the therapeutic potential of statins in oncology. Translational Cancer Research, 13(9), 4671-4677. https://doi.org/10.21037/tcr-24-576

Vancouver

Wang J, Cao G, Liu Y, Chen S, Li H, Zheng B. Mendelian randomization study on simvastatin and gastric cancer: exploring the therapeutic potential of statins in oncology. Translational Cancer Research. 2024;13(9):4671-4677. doi:10.21037/tcr-24-576

BibTeX
@article{Wang2024,
  author = {Wang, Jiazhong and Cao, Gang and Liu, Yang and Chen, Suo and Li, Haoyu and Zheng, Bo},
  title = {Mendelian randomization study on simvastatin and gastric cancer: exploring the therapeutic potential of statins in oncology},
  journal = {Translational Cancer Research},
  year = {2024},
  volume = {13},
  number = {9},
  pages = {4671--4677},
  doi = {10.21037/tcr-24-576}
}
Kostenlos starten →